Biotech News

LeMaitre to Participate at Upcoming Investor Conferences in June

LeMaitre Vascular (LMAT)LeMaitre VascularConference / presentation

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June.

Jefferies Global Healthcare Conference Wednesday, June 3, 2026 Marriott Marquis, New York City Management will participate in a fireside chat at 10:30 AM EDT

Goldman Sachs Annual Global Healthcare Conference Wednesday, June 10, 2026 Loews Miami Beach Hotel, Miami Beach Management will present at 9:20 AM EDT

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com .

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Related news

LeMaitre Vascular

Vascular Device Company LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease. Its portfolio is focused on open surgical and endovascular procedures outside the heart. Grafts and Biological Implants The company offers synthetic vascular grafts, Artegraft biological...

Recent company news

Stock data

Close
79.05 USD
Market cap
2.09B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States